✨ Your Portfolio is fetched and updated from zerodha.
Small Miscellaneous

Novartis India Ltd.

NOVARTIND

Market Cap
₹3,635 Cr.
P/E
39.02

Novartis India Ltd.

  • Novartis India
  • Gufic Biosciences
  • Panacea Biotec
  • TJI Pharma - Small Cap

FAQs on Novartis India Ltd. Shareprice

Novartis has given lower returns compared to its competitors.
Novartis has grown at ~9.99% over the last 9yrs while peers have grown at a median rate of 19.94%

Yes, Novartis is expensive.
Latest PE of Novartis is 38.91, while 3 year average PE is 29.34.
Also latest EV/EBITDA of Novartis is 31.44 while 3yr average is 23.58.

View FAQ's On Business

Growth Table

  • Novartis India Ltd.
  • Gufic Biosciences
  • Panacea Biotec

Balance Sheet

  • Novartis India Ltd.
  • Gufic Biosciences
  • Panacea Biotec

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Novartis India Ltd.
  • Gufic Biosciences
  • Panacea Biotec

Cash Flow

  • Novartis India Ltd.
  • Gufic Biosciences
  • Panacea Biotec

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Novartis India Ltd.
  • Gufic Biosciences
  • Panacea Biotec

Quarterly Results

  • Novartis India Ltd.
  • Gufic Biosciences
  • Panacea Biotec

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Novartis India Ltd. Financials

Balance sheet of Novartis is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Novartis is increasing.
Latest net debt of Novartis is -₹667.7 Crs as of Mar-26.
This is greater than Mar-25 when it was -₹1,296.06 Crs.

The profit is oscillating.
The profit of Novartis is ₹93.18 Crs for TTM, ₹101 Crs for Mar 2025 and ₹85.19 Crs for Mar 2024.

The company seems to pay a good stable dividend.
Novartis latest dividend payout ratio is 61.15% and 3yr average dividend payout ratio is 82.33%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech